Centre de Recherche Dermatologique du Québec Métropolitain

Recent papers from Centre de Recherche Dermatologique du Québec Métropolitain

1. Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trialsNature Medicine · 2026
2. Cost-effectiveness of early versus delayed disease-modifying antirheumatic drugs for psoriatic arthritisThe Lancet Regional Health - Americas · 2026
3. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trialsThe Lancet · 2018
4. Pushing the Boundaries of Topical Therapy in Patients with Atopic Dermatitis: A Review of Baseline Disease Severity and Burden in Clinical TrialsDermatology and Therapy · 2026
5. A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamicsFrontiers in Medicine · 2026
6. Durability of response to icotrokinra for high‐impact site psoriasis: 1‐year ICONIC ‐ TOTAL findingsJournal of the European Academy of Dermatology and Venereology · 2026
7. Approach to the Assessment and Management of Adult Patients With Prurigo Nodularis: A Canadian ConsensusDermatologic Therapy · 2026
8. A practical framework for treating-to-target in chronic hand eczemaJournal of the American Academy of Dermatology · 2026
9. G2‐PASE: A Novel, Rapid, and Reliable Measure of Plaque Psoriasis SeverityJEADV Clinical Practice · 2026
10. Considerations for Treating Generalized Pustular Psoriasis (GPP): A Narrative ReviewDermatology and Therapy · 2025
11. Supporting evidence and recommendations for the management of patients with systemic-eligible atopic dermatitis: A Canadian consensus documentJAAD International · 2025
12. Canadian Consensus Guidelines for the Management of Atopic Dermatitis with Topical TherapiesDermatology and Therapy · 2025
13. Canadian Consensus Guidelines for the Management of VitiligoDermatology and Therapy · 2025
14. Mission impossible? Caveats in interpreting and comparing long‐term efficacy in biologic studies for moderate‐to‐severe plaque psoriasisJournal of the European Academy of Dermatology and Venereology · 2025
15. Burden of Vitiligo in Canada: Retrospective Analysis of a Canadian Public Claims DatabaseJournal of Cutaneous Medicine and Surgery · 2025
16. IL-23 blockade in a patient with psoriasis and Toxoplasma gondii reactivation history: Case report and reviewSAGE Open Medical Case Reports · 2025
17. Considerations for defining and diagnosing generalized pustular psoriasisJournal of the European Academy of Dermatology and Venereology · 2024
18. Gender-Affirming Vaginoplasty: A Comparison of Algorithms, Surgical Techniques and Management Practices across 17 High-volume Centers in North America and EuropePlastic & Reconstructive Surgery Global Open · 2023
19. The Montréal Classification of urethral lengthening for phalloplasty in transmasculine patients—surgical techniques and urethral complicationsInternational Journal of Transgender Health · 2022
20. The benefit of scratch patch testing to demonstrate ocular contact allergy to brimonidine tartrateContact Dermatitis · 2022